Press release
HER2 Inhibitors Market Size, Share, Segment Analysis And Forecast To 2033
HER2 Inhibitors Market Size
As per the report, the her2 inhibitors market size has grown strongly in recent years. It will grow from $8.77 billion in 2023 to $9.64 billion in 2024 at a compound annual growth rate (CAGR) of 9.9%. The her2 inhibitors market size is expected to see strong growth in the next few years. It will grow to $13.61 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%.
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3396&type=smp
Increasing Incidence Of Breast Cancer Cases Fuels The Her-2 Inhibtors Market Growth
The rise in the number of breast cancer cases across the globe is likely to contribute to the growth of the HER-2 inhibitors market during the forecast period. For instance, in January 2022, according to the American Cancer Society, there will likely be 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the US, or roughly 1,670 fatalities every day. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all new cancer cases. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all new cancer cases. Therefore, the rise in the breast cancer incidence rate globally is anticipated to boost the demand for the HER-2 inhibitors market over the forthcoming years.
Increasing Focus On Developing Treatment Forher2-Low Breast Cancerto Gain A Competitive Edge
Major companies operating in the HER2 inhibitor market are focused on developing treatments for HER2-low breast cancer to gain a competitive edge in the market. HER2-low breast cancer is a newly defined subset of HER2-negative breast cancer, which includes tumors that do not overexpress or make too many copies of the HER2 protein. For instance, in August 2022, AstraZeneca PLC, a UK-based pharmaceutical and biotechnology company, the U.S. Food and Drug Administration (FDA) approved Enhertu (fam-trastuzumab deruxtecan-nxki) as the first HER2-directed therapy for patients with HER2-low metastatic breast cancer. Enhertu is prescribed via intravenous infusion to address HER2-low (IHC 1+ or IHC 2+/ISH-) breast cancer in adults who have undergone prior metastatic chemotherapy or experienced disease recurrence within six months of completing adjuvant chemotherapy.
The her2 inhibitors market covered in this report is segmented -
1) By Treatment: Monotherapy, Combination Therapy
2) By Application: Squamous Cell Carcinoma, Adenocarcinoma, Large Cell Carcinoma, Breast Cancer, Other Applications
3) By End User: Hospitals, Clinics, Other End Users
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=3396&type=discount
Major companies operating in the her2 inhibitors market report are Pfizer Inc., Johnson & Johnson Services Inc., F Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Takeda Pharmaceutical Company Limited, Eli Lilly International Corp., Gilead Sciences Inc., C.H. Boehringer Sohn AG & Co. KG, Applied Molecular Genetics Inc., Viatris Inc. US, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Catalent Inc., Ipsen SA, Cipla Limited, the Pierre Fabre Group, Biocon Biopharmaceuticals Pvt. Ltd., Innovent Biologics Inc., Halozyme Therapeutics Inc., Seattle Genetics Inc., Zymeworks Inc., Puma Biotechnology Inc., MacroGenics Inc., Mersana Therapeutics Inc., Cellestia Biotech AG
Contents of the report:
1. Executive Summary
2. HER2 Inhibitors Market Report Structure
3. HER2 Inhibitors Market Trends And Strategies
4. HER2 Inhibitors Market - Macro Economic Scenario
5. HER2 Inhibitors Market Size And Growth
…..
27. HER2 Inhibitors Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/her2-inhibitor-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release HER2 Inhibitors Market Size, Share, Segment Analysis And Forecast To 2033 here
News-ID: 3577634 • Views: …
More Releases from The Business Research Company
Growth Patterns, Market Segmentation, and Competitive Approaches Influencing the …
The formic acid industry is poised for significant expansion in the coming years, driven by several emerging trends and increasing demand across various sectors. This growth is supported by innovations in sustainable production and applications in diverse industries, setting the stage for dynamic market developments through 2030.
Expected Market Value and Growth Outlook of the Formic Acid Market
The formic acid market is projected to reach a value of $2.45…
Leading Companies Reinforcing Their Presence in the Foam Tape Market
The foam tape industry is on track for significant expansion in the coming years, driven by advancements in technology and growing demand across various sectors. This market is experiencing evolving applications and innovations that promise to reshape its landscape through 2030 and beyond.
Foam Tape Market Size and Growth Outlook
Projected to reach $15.78 billion by 2030, the foam tape market is anticipated to grow at a steady compound annual…
Future Perspective: Key Trends Shaping the Flame Retardants Market Until 2030
The flame retardants market is poised for significant expansion as industries increasingly prioritize safety and sustainability. With rapid advancements in material technologies and growing regulatory emphasis, this market is set to evolve substantially in the coming years. Let's explore its expected growth, leading companies, emerging trends, and market segmentation to understand the factors shaping its future.
Flame Retardants Market Size Forecast Through 2030
The market for flame retardants is projected…
Analysis of Key Market Segments Driving the Fertilizer Additives Market
The fertilizer additives market is attracting considerable attention due to its essential role in enhancing agricultural productivity and sustainability. With growing concerns about environmental impact and the need for efficient farming practices, this market is set to experience notable growth in the coming years. Let's explore its expected size, leading players, key trends, and segmentation to understand its evolving landscape.
Forecasted Expansion of the Fertilizer Additives Market by 2030
The…
More Releases for HER2
HER2-Positive Breast Cancer (HER2+ BC) Clinical Market to Reach USD 21.46 Billio …
Sub-Headline: The global HER2-Positive Breast Cancer Clinical Market is expected to rise from USD 13.82 billion in 2023 to USD 21.46 billion by 2030, registering a CAGR of 6.5%, driven by rapid uptake of antibody-drug conjugates (ADCs), dual-targeted therapies, and AI-enabled precision oncology diagnostics.
Introduction
The HER2-Positive Breast Cancer (HER2+ BC) Clinical Market is undergoing a major transformation fueled by next-generation targeted therapies, breakthrough ADCs, biosimilar expansion, and genomic testing advancements. HER2+…
Evolving Market Trends In The HER2-Positive Breast Cancer Industry: Innovative T …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What Is the Expected HER2-Positive Breast Cancer Market Size During the Forecast Period?
Over the past few years, there has been a noteworthy expansion in the HER2-positive breast cancer market. The market, which is projected to increase from $10.21 billion in 2024 to $10.96 billion in the following year, predicts a compound annual growth…
HER2 Inhibitors: Advancing Breast Cancer Treatments
"The Business Research Company recently released a comprehensive report on the Global HER2 Inhibitors Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
HER2 Positive Breast Cancer Pipeline Drugs 2024
DelveInsight's, "HER2 Positive Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 60+ companies and 65+ pipeline drugs in HER2 Positive Breast Cancer pipeline landscape. It covers the HER2 Positive Breast Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the HER2 Positive Breast Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in…
HER2 Inhibitors: Targeted Therapies Transforming Cancer Treatment
HER2 inhibitors market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 9% in the above mentioned forecast period.
Global HER2 Inhibitors Market Scope and Market Size
The HER2 inhibitors market is segmented on the basis of treatment, application, end-users and distribution channel. The growth amongst these segments will help you analyze…
ADC Drugs For HER2 Positive Breast Cancer
According to the latest data, breast cancer has overtaken lung cancer to become the most common cancer among women, and the death rate is the second highest among female tumors, seriously affecting the physical and mental health of women around the world. Patients with abnormal expression of human epidermal growth factor receptor (HER2) account for 15%-20% of all breast cancers, which is highly invasive and has poor prognosis.
Although more drug…
